Status:
COMPLETED
Streaming Web-based Exercise At Home: A Pilot Study
Lead Sponsor:
Celina Shirazipour
Conditions:
Prostate Cancer
Breast Cancer Female
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This is a single-arm pilot study to evaluate the use of web-based video conferencing as a method of exercise training delivery. This study will include 10 female breast cancer survivors and 10 male pr...
Eligibility Criteria
Inclusion
- Male previously diagnosed with prostate cancer or female previously diagnosed with breast cancer.
- For breast cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable.
- For prostate cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for androgen receptor-targeted therapies (such as enzalutamide, apalutamide, darolutamide, or abiraterone). Patients currently on active surveillance are eligible even if they have not received prior anti-cancer treatment.
- Has access to tablet, laptop, or desktop computer with video capabilities connected to the internet with a screen at least 13 inches across.
- Physically able to complete modified Bruce submaximal treadmill test, leg strength test, grip strength test, and InBody per patient self-assessment.
- Physician clearance to participate in this study. Can be done through review of patients' medical records.
- Ability to read, write, and understand English.
- Has a chair at home to use for exercise that is not on wheels and has a solid back (not a reclining chair).
- Ambulatory without assistance.
- Has a clear 5 x 6-foot space at home in which to exercise.
- Age \>18 years.
- Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
Exclusion
- Active treatment planned within the next 6 months. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for AR-targeted therapies for prostate cancer.
- Known metastatic disease.
- Grade 3 or higher peripheral neuropathy.
- Major surgery within 3 months of baseline visit.
- Positive pregnancy test for women of child-bearing potential.
- Answers yes to any question on the Physical Activity Readiness Questionnaire unless study participation is cleared by a physician.
- Known allergy to Fitbit device.
- Currently meeting physical activity guidelines (score of \>23 on Godin-Shephard Leisure-Time Physical Activity Questionnaire).
Key Trial Info
Start Date :
July 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04282967
Start Date
July 7 2020
End Date
March 30 2023
Last Update
April 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars Sinai Medical Center
Los Angeles, California, United States, 90048